A cikin 'yan shekarun nan, tare da saurin ci gaba na fasahar bincike na in vitro na duniya, reagents na hematology, a matsayin ainihin abubuwan da ake amfani da su don gwajin asibiti, sun zama abin da ke mayar da hankali ga masana'antu don inganta aikin. Ana amfani da reagents na Hematology galibi don nazarin ƙwayoyin jini, gwajin aikin coagulation da sauran ayyukan. Hankalin su, daidaito da kwanciyar hankali suna shafar amincin sakamakon binciken kai tsaye.
Dangane da alamomin aiki, reagents na zamani na ilimin halittar jini suna haɓaka zuwa mafi girman daidaito, ƙarfi da ƙarfin tsoma baki da mafi girman kewayon ganowa. Yin amfani da reagents na nazarin kwayoyin jini a matsayin misali, sabon ƙarni na reagents yana rage tsangwama na samfurori masu rikitarwa irin su lipemia da jaundice ta hanyar inganta tsarin surfactant da tsarin buffer, yayin da inganta ikon gano kwayoyin da ba su da girma da kuma kwayoyin da ba su da kyau. Bugu da kari, yaɗawar kayan aikin gwaji mai sarrafa kansa ya sanya ƙarin buƙatu don bambancin tsari da kwanciyar hankali na reagents. A halin yanzu, samfuran manyan kamfanoni sun sami ƙimar CV (ƙimar bambancin) ƙasa da 3%, wanda ya zarce matsakaicin masana'antu.
Bayanai na kasuwa sun nuna cewa girman kasuwar hematology reagent ana sa ran zai kai dalar Amurka biliyan $XX a cikin 20XX, tare da adadin haɓakar fili na shekara-shekara fiye da XX%. Wannan ci gaban ya samo asali ne saboda karuwar saka hannun jarin likitanci a kasuwanni masu tasowa da kuma ci gaba da neman manyan samfuran bincike na ƙarshe a cikin ƙasashe masu tasowa. Ya kamata a lura cewa, kasar Sin da sauran yankuna suna hanzarta inganta masana'antu ta hanyar ba da goyon baya ga manufofi da sabbin fasahohi, kuma a hankali kamfanonin cikin gida sun tunkari matakin farko na kasa da kasa{5} wajen daidaita ma'auni.
Daga hangen nesa na fasaha trends, hematological reagents zai warai hade wucin gadi algorithms a nan gaba, da kuma inganta zane na dauki tsarin ta hanyar babban bayanai bincike. A lokaci guda, manufar kare muhallin kore yana haɓaka haɓakar reagents ta hanyar ƙarancin guba da lalacewa, kuma wasu kamfanoni sun ƙaddamar da samfuran da ba su da alaƙa da muhalli kamar cyanide{1}}waɗanda ke samar da haemolytic kyauta. Bugu da ƙari, fashewar buƙatun batu{3}}na{4}}gwajin kulawa (POCT) ya haifar da ci gaba a cikin reagent miniaturization da fasahar adana zafin ɗaki, yana samar da mafi dacewa mafita ga cibiyoyin kiwon lafiya na farko.
A halin yanzu, gasar wasan kwaikwayon na reagents na hematological ya zama babban yanki don ci gaban fasaha a cikin masana'antar bincike ta in vitro. Tare da aikace-aikacen sabbin kayan aiki da shigar da fasahar kere kere na fasaha, wannan sashin kasuwa zai ci gaba da sakin sabbin kuzari da samar da ingantattun kayan aikin bincike don masana'antar kiwon lafiya da kiwon lafiya ta duniya.